Related Experiment Video
Updated: Jun 3, 2026

Programming Stem Cells for Therapeutic Angiogenesis Using Biodegradable Polymeric Nanoparticles
Published on: September 27, 2013
[Therapeutic angiogenesis using gene transfer and stem cell therapy in peripheral artery disease]
1Chefärztin Klinische und Interventionelle Angiologie, Asklepios Klinik St.Georg, Lohmühlenstr. 5, 20099 Hamburg. s.nikol@asklepios.com
Abstract:
The world-wide largest angiogenesis gene therapy trial in 525 patients suffering from critical limb ischemia and treated with the non-viral gene construct for fibroblast growth factor (NV1FGF) or placebo was negative for all endpoints. Also, stem cell or progenitor cell therapy did no reveal clinical benefit in patients with peripheral artery disease. Data from large randomized placebo-controlled are still not available.
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Mechanism of Angiogenesis
Regulation of Angiogenesis and Blood Supply
Peripheral Artery Disease IV: Nursing Management
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Gene Therapy

